Sign in
8-K

Current Report

Oruka Therapeutics, Inc. Filed Acc 0001564590-20-042033

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading abio-8k_20200829.htm…